GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Synmosa Biopharma Corp (ROCO:4114) » Definitions » PB Ratio

Synmosa Biopharma (ROCO:4114) PB Ratio : 1.97 (As of Dec. 15, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Synmosa Biopharma PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-15), Synmosa Biopharma's share price is NT$33.00. Synmosa Biopharma's Book Value per Share for the quarter that ended in Sep. 2024 was NT$16.72. Hence, Synmosa Biopharma's PB Ratio of today is 1.97.

Good Sign:

Synmosa Biopharma Corp stock PB Ratio (=1.97) is close to 2-year low of 1.97

The historical rank and industry rank for Synmosa Biopharma's PB Ratio or its related term are showing as below:

ROCO:4114' s PB Ratio Range Over the Past 10 Years
Min: 1.09   Med: 1.72   Max: 3.29
Current: 1.97

During the past 13 years, Synmosa Biopharma's highest PB Ratio was 3.29. The lowest was 1.09. And the median was 1.72.

ROCO:4114's PB Ratio is ranked better than
51.81% of 940 companies
in the Drug Manufacturers industry
Industry Median: 2.075 vs ROCO:4114: 1.97

During the past 12 months, Synmosa Biopharma's average Book Value Per Share Growth Rate was 8.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 12.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 11.20% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 8.90% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Synmosa Biopharma was 24.90% per year. The lowest was 1.80% per year. And the median was 11.20% per year.

Back to Basics: PB Ratio


Synmosa Biopharma PB Ratio Historical Data

The historical data trend for Synmosa Biopharma's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synmosa Biopharma PB Ratio Chart

Synmosa Biopharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.61 1.51 1.49 3.00 2.22

Synmosa Biopharma Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.24 2.22 2.26 2.29 2.24

Competitive Comparison of Synmosa Biopharma's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Synmosa Biopharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synmosa Biopharma's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Synmosa Biopharma's PB Ratio distribution charts can be found below:

* The bar in red indicates where Synmosa Biopharma's PB Ratio falls into.



Synmosa Biopharma PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Synmosa Biopharma's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=33.00/16.722
=1.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Synmosa Biopharma  (ROCO:4114) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Synmosa Biopharma PB Ratio Related Terms

Thank you for viewing the detailed overview of Synmosa Biopharma's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Synmosa Biopharma Business Description

Traded in Other Exchanges
N/A
Address
No. 6, Gongye 1st Road, Hukou Township, Hsinchu County, Hsinchu, TWN
Synmosa Biopharma Corp is engaged in the research and development, manufacturing, marketing, and distribution of pharmaceutical products, medical devices, cosmetics, animal drugs, chemical food additives, and beverages. It is also involved in manufacturing and sales, and environmental drugs wholesale (retail), as well as the import and export of related businesses. The company provides prescription, OTC medicines, and healthcare products under its Synmosa trademark. The reporting segments of the company are; the Generic Drugs segment which derives key revenue, and the Active Pharmaceutical Ingredients segment.

Synmosa Biopharma Headlines

No Headlines